June 21, 2012
An Ohio federal judge on Thursday blocked Abbott Laboratories' bid to toss a suit by generic-drug maker Roxane Laboratories Inc. challenging two of Abbott's patents for its HIV drug Norvir in Roxane's effort to market generic versions of the drug.